Found: 73
Select item for more details and to access through your institution.
Radiolabeled Antibodies for Cancer Imaging and Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1454, doi. 10.3390/cancers14061454
- By:
- Publication type:
- Article
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e190, doi. 10.1016/j.clml.2022.11.010
- By:
- Publication type:
- Article
Receptor Occupancy Imaging Studies in Oncology Drug Development.
- Published in:
- AAPS Journal, 2018, v. 20, n. 2, p. 1, doi. 10.1208/s12248-018-0203-z
- By:
- Publication type:
- Article
Theranostics of Neuroendocrine Tumors.
- Published in:
- Visceral Medicine, 2017, v. 33, n. 5, p. 358, doi. 10.1159/000480383
- By:
- Publication type:
- Article
Flourine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging of Peritoneal Carcinomatosis in Lung Cancer: A Case Study.
- Published in:
- World Journal of Nuclear Medicine, 2024, v. 23, n. 3, p. 202, doi. 10.1055/s-0044-1778708
- By:
- Publication type:
- Article
Unusual location of recurrent mantle cell lymphoma on fluorodeoxyglucose‑positron emission tomography despite complete metabolic resolution of previous sites of disease.
- Published in:
- World Journal of Nuclear Medicine, 2020, v. 19, n. 3, p. 277, doi. 10.4103/wjnm.WJNM_65_19
- By:
- Publication type:
- Article
Predicting primary treatment failure using interim FDG‐PET scanning in diffuse large B‐cell lymphoma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 4, p. 475, doi. 10.1111/ejh.13684
- By:
- Publication type:
- Article
Therapeutic efficacy of <sup>177</sup>Lu-CHX-A″-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
- Published in:
- Prostate, 2009, v. 69, n. 1, p. 92, doi. 10.1002/pros.20856
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG Metabolic Tumor Volume: Association with Short- and Long-Term Feeding Tube Use in Head and Neck IMRT.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Guiding principles on the education and practice of theranostics.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2320, doi. 10.1007/s00259-024-06657-2
- By:
- Publication type:
- Article
A patient journey audit tool (PJAT) to assess quality indicators in a nuclear medicine service.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 7, p. 1816, doi. 10.1007/s00259-024-06627-8
- By:
- Publication type:
- Article
FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1287, doi. 10.1007/s00259-023-06548-y
- By:
- Publication type:
- Article
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4661, doi. 10.1007/s00259-022-05918-2
- By:
- Publication type:
- Article
The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 2, p. 428, doi. 10.1007/s00259-020-04967-9
- By:
- Publication type:
- Article
Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2461, doi. 10.1007/s00259-020-04731-z
- By:
- Publication type:
- Article
Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 6, p. 1476, doi. 10.1007/s00259-020-04706-0
- By:
- Publication type:
- Article
Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1609, doi. 10.1111/imj.15533
- By:
- Publication type:
- Article
Ventilation perfusion lung SPECT/CT in pregnancy during COVID‐19.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Nuclear medicine in the era of personalised medicine.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Impact of 18F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative <sup>131</sup>I whole body scan and elevated serum thyroglobulin.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2022, v. 10, n. 1, p. 20, doi. 10.22038/AOJNMB.2021.58276.1406
- By:
- Publication type:
- Article
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2014, v. 2, n. 1, p. 3
- By:
- Publication type:
- Article
ACTR-55. TUMOR VOLUME AS A PREDICTOR OF RESPONSE TO ANTI-EGFR ADC ABT-414.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi24, doi. 10.1093/neuonc/noy148.087
- By:
- Publication type:
- Article
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
IC-P-012: C-11 PIB and F-18 FDG in the diagnosis of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-291: C-11 PIB and F-18 FDG in the diagnosis of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
IC-P-012: C-11 PIB and F-18 FDG in the diagnosis of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-291: C-11 PIB and F-18 FDG in the diagnosis of Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 747, doi. 10.1007/s10637-022-01237-3
- By:
- Publication type:
- Article
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.
- Published in:
- Rheumatology, 2018, v. 57, n. 2, p. 345, doi. 10.1093/rheumatology/kex411
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F-FMISO PET and <sup>18</sup>F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.606210
- By:
- Publication type:
- Article
Hypoxia-targeted radiotherapy dose painting for head and neck cancer using <sup>18</sup>F-FMISO PET: A biological modeling study.
- Published in:
- Acta Oncologica, 2013, v. 52, n. 8, p. 1723, doi. 10.3109/0284186X.2012.759273
- By:
- Publication type:
- Article
President's Report.
- Published in:
- ANZ Nuclear Medicine, 2010, v. 41, n. 4, p. 5N
- By:
- Publication type:
- Article
President's Report.
- Published in:
- ANZ Nuclear Medicine, 2010, v. 41, n. 3, p. 5N
- By:
- Publication type:
- Article
Incoming President's Report.
- Published in:
- ANZ Nuclear Medicine, 2010, v. 41, n. 2, p. 5N
- By:
- Publication type:
- Article
Scientific basis of personalised tomographic radiation planning for radioembolisation: A form of brachytherapy planning.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Are we ready for dual-time point FDG PET imaging?
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2011, v. 55, n. 3, p. 320, doi. 10.1111/j.1754-9485.2011.02274.x
- By:
- Publication type:
- Article
Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 6, p. 986, doi. 10.2967/jnumed.123.265603
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.253146
- By:
- Publication type:
- Article
Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.254508
- By:
- Publication type:
- Article
Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.247197
- By:
- Publication type:
- Article
Global Issues of Radiopharmaceutical Access and Availability: a Nuclear Medicine Global Initiative Project.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.247197
- By:
- Publication type:
- Article